Compass Pathways Akcija

Compass Pathways ROCE

Vrijednost ROCE (Return on Capital Employed) od Compass Pathways (CMPS) na dan 24. јул 2026. je -115,20 %. Prethodne godine, ROCE (Return on Capital Employed) je bio -56,31 % — promjena od 104,57% (niži).

ROCE

-115,20 %

YoY

104,57%

Zadnja ažuriranja:

U godini 2026 rentabilnost uloženog kapitala (ROCE) kompanije Compass Pathways iznosila je -115,20 %, što je porast od 104,57% u poređenju sa -56,31 % ROCE prethodne godine.

Access this data via the Eulerpool API

Compass Pathways Анализа акција

Šta radi Compass Pathways? Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways je jedna od najpopularnijih kompanija na Eulerpool.

ROCE у детаљу

Otkrivanje profitabilnosti upotrebljenog kapitala (ROCE) kompanije Compass Pathways

Profitabilnost upotrebljenog kapitala (ROCE) kompanije Compass Pathways je finansijski pokazatelj koji meri profitabilnost i efikasnost kompanije u pogledu uloženog kapitala. Izračunava se deljenjem dobiti pre kamata i poreza (EBIT) sa uloženim kapitalom. Viši ROCE ukazuje na to da kompanija efektivno koristi svoj kapital za stvaranje dobiti.

Godišnji poređenja

Godišnja analiza ROCE kompanije Compass Pathways pruža dragoceni uvid u njenu efikasnost korišćenja kapitala u svrhu ostvarivanja dobiti. Porast ROCE ukazuje na poboljšanu profitabilnost i operativnu efikasnost, dok pad može signalizirati moguće probleme u korišćenju kapitala ili poslovanju.

Utjecaj na investicije

ROCE kompanije Compass Pathways je ključni faktor za investitore i analitičare pri oceni efikasnosti i profitabilnosti kompanije. Viši ROCE može učiniti kompaniju privlačnom za ulaganje, jer često ukazuje na to da kompanija ostvaruje adekvatnu dobit iz svog uloženog kapitala.

Interpretacija fluktuacija ROCE

Promene u ROCE kompanije Compass Pathways su rezultat varijacija u EBIT-u ili upotrebljenom kapitalu. Te fluktuacije pružaju uvid u operativnu efikasnost, finansijsku izvedbu i strategijsko upravljanje finansijama kompanije i pomažu investitorima u donošenju informisanih odluka.

Često postavljena pitanja o akciji Compass Pathways

ROCE (Return on Capital Employed) kompanije Compass Pathways iznosi -115,20 % u 2026. godini.

Access this data via the Eulerpool API

Профитабилност — Compass Pathways

Sve ključne metrike — Compass Pathways

Раст